In conclusion, our data show that T-LGL leukemia with specific molecular and phenotypic patterns is associated with discrete clinical features contributing to get insights into molecular bases accounting for the development of Fas ligand-mediated neutropenia. This evidence concerns the gene FASLG and T-cell large granular lymphocyte leukemia.